Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

RECRUITING

Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchathewi

RECRUITING

National Cancer Center, Goyang-si

RECRUITING

Mackay Memorial Hospital, Taipei

RECRUITING

Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok

RECRUITING

"Municipal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council", Dnipro

RECRUITING

"Regional Municipal Non-profit Enterprise Bukovinian Clinical Oncology Center", Chernivtsi

RECRUITING

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

ACTIVE_NOT_RECRUITING

Municipal non-profit enterprise Regional Clinical Hospital of Ivano-Frankivsk Regional Council, Ivano-Frankivsk

RECRUITING

UCSF Medical Center at Mission Bay, San Francisco

RECRUITING

Cancer Hospital Chinese Academy of Medical Science, Beijing

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

The First Hospital of China Medical University, Shenyang

RECRUITING

The First hospital of Jilin University, Changchun

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou

RECRUITING

National Cheng Kung University Hospital, Tainan City

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Seoul National University Hospital, Seoul